Phase I/Ii study of mTOR inhibitor everolimus and Hyper-CVAD plus RAD001 (Everolimus) chemotherapy in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
Ontology highlight
ABSTRACT: Analysis of the effects of everolimus on gene expression and if this correlates to drug and/or clinical response.
ORGANISM(S): Homo sapiens
PROVIDER: GSE60540 | GEO | 2017/01/01
SECONDARY ACCESSION(S): PRJNA258503
REPOSITORIES: GEO
ACCESS DATA